Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy - Test2 - elhamkhani - TriplyDB

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

http://www.wikidata.org/entity/Q30432684

about

Continuation and maintenance treatments for depression in older people Major depressive disorder in older adults: benefits and hazards of prolonged treatment Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis.The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning Anxiety disorders: new developments in old age Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment?Cognitive functioning and late-life depression.Late-life depression in the primary care setting: challenges, collaborative care, and prevention Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder.Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructure Psychosocial Risk Factors for Cognitive Decline in Late-Life Depression: Findings from the MTLD-III Study Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.Early intervention to reduce the global health and economic burden of major depression in older adults Cognition in older adults with bipolar disorder versus major depressive disorder.Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial Continuation and maintenance treatments for depression in older people.Speed of processing and depression affect function in older adults with mild cognitive impairment Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.Antidepressant Use and Cognitive Decline: The Health and Retirement Study Directions for Effectiveness Research to Improve Health Services for Late-Life Depression in the United States Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?Late-life depression, mild cognitive impairment and hippocampal functional network architecture.The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease.Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.Resting state functional connectivity and treatment response in late-life depression.Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.Cognition in Late Life Depression: Treatment Considerations.The nuances of cognition and depression in older adults: the need for a comprehensive assessment.Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.Unmet needs and research challenges for late-life mood disorders.Risk factors for the progression of mild cognitive impairment to dementia.Dysthymic disorder in the elderly population.Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.Tau in Late-Life Depression: A Systematic Review and Meta-Analysis.Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.

P2860

Q24202971-3327E205-C8D8-49B1-88EC-0973766DB271 Q27003857-8768CF5D-3DC8-4357-9BD4-ECAE0DD06547 Q27026362-05BF86B8-421F-4A64-AFF3-DCAF13A9E0C7 Q30252001-74539815-7332-4B36-A9E2-53F45C6572DD Q33578766-E3A34500-1F6D-4D67-A458-ABC8BD8142D5 Q33768456-2D6BC201-06AD-4E7B-8F17-454E0D309969 Q33898173-8805D960-3DB0-4B62-BF90-1C289CDA9EBC Q33934847-0E8C062E-215F-4284-B143-53B93FF81E54 Q33937216-AAC70268-C499-498D-AB64-DF0868D25AAC Q34214287-395CFAFE-E866-4640-9A08-15BFFF775BA7 Q35217858-B1377C89-3A57-4150-B0D7-7E4768D1748C Q35596915-21A4C59C-74A1-4D52-9464-8E61664224CC Q35805783-EB4C90CB-4928-4111-BC07-61534A88F89F Q35828096-560B0EE3-3B7D-49C0-99BE-DA2142632A6D Q35974372-5237C39C-0C83-416B-AC1E-42D0380AB6FA Q36048458-67845537-9930-4509-B284-83B1AC946FE4 Q36094950-D19E8F2F-04ED-447F-94D9-182668625D52 Q36127393-085EEDC4-F6CC-4229-BC00-52798B028EF7 Q36137212-E8790BF3-BE3F-4923-9B68-D9C3BFF28577 Q36148702-361E6C64-DE24-47EE-BD18-9A26E0EA20EC Q36201714-C2E4F388-6843-4D72-B4CF-845E662AC4DB Q36446578-581617D3-E7D5-4874-B832-84D010D8C17D Q36477780-4EF7B1D1-5FF3-4E9D-8416-F07DC617F1BF Q36609643-56C75E49-8E37-4105-888A-540B8A800256 Q36673394-7A3E2674-0BFA-4DA5-A347-F4227DF364C9 Q37272637-ACE99673-8DF6-436C-97F4-916AC8C2B6C8 Q37359969-96C2A46F-C7AB-4022-AEFC-69D67A44F608 Q37376724-B2625C00-FF00-4C44-B766-7BC32AD6690E Q37397964-BF7C6ACB-0681-4909-AEC8-B26A8884006C Q37579433-0DE892ED-9927-471E-9EE0-D778A6E8ACFC Q37653424-0C07F7A0-8181-404A-ACA1-3D574E87FD4A Q37684863-4FE7964D-ECC2-4C15-9891-F8F64F7B862F Q37694916-A5D642DA-6CB6-4595-A9E7-985D7BD8F5B4 Q37993335-1D90080F-9521-442B-A9E5-32B68180E35E Q38147018-0985FC03-D1A1-410C-8E57-EEB3EF2E15AB Q38149355-B73343C3-15FB-47A6-96A0-8549D6FDFA1C Q38155015-CE6A20A5-E77B-4B3B-8AF3-CB11A3386124 Q38208461-1E349493-EDD3-4DCE-BB77-18E6B763481A Q38920533-96930E9E-0992-4A5E-8760-22E11CCD0FAA Q39301254-A7E6E4FF-D916-4909-B8C4-6CF1B23FF065

P2860

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

http://www.wikidata.org/entity/Q30432684

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@ast

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@en

type

label

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@ast

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@en

prefLabel

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@ast

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@en

P1433

Q30432684-C0F4142E-7D64-4C4F-84E7-E41DC89E40FD

P1476

Q30432684-03271586-684A-40C0-A8FF-4FD840D544A9

P2093

Q30432684-0A3E87DA-4BA2-41D7-B22D-6E6FD2402B6B

Q30432684-112C23DE-9C41-4B6F-980E-89BE021832BD

Q30432684-1621CB63-7278-498C-BB12-0DB8349A0C89

Q30432684-1AB0F18E-CEDC-4E8D-9EEF-99D53C2CDAFD

Q30432684-1D7D76D4-54FC-484C-ADB6-AE4B6A9F645C

Q30432684-3F578C81-7747-413F-AD73-A06532F96E24

Q30432684-4949F914-DAF8-4013-8F24-B86E51125842

Q30432684-4C884D33-8015-43A8-BE3F-F2EA88BCE12D

Q30432684-51C7AFEA-F66D-4629-A82F-96953D2BBF7A

Q30432684-74C292FE-7A5C-4D69-94EA-49F9EEDCCE60

P2860

Q30432684-0378ECFA-3397-45F9-8177-19830906112C

Q30432684-1020B118-DA8E-4C7E-9BAA-D8BD347B76F6

Q30432684-2E7AB84B-ED3A-433D-B9C7-77F4C9690A34

Q30432684-31BB636B-6A43-4E5E-8342-95743AD044F9

Q30432684-3DA3389C-AD34-4C0C-82A2-53E53C94AC53

Q30432684-42C03F66-786B-48D8-86B7-95419E3222F7

Q30432684-42FF27F3-09B5-462E-8975-AAEF6AA17255

Q30432684-4402A0BB-C98E-4A7D-8063-92A4457FE406

Q30432684-490C912D-3878-4DD5-A7D5-8D4362BA8DA6

Q30432684-4A575367-ECE0-4ABD-A8ED-D389354A92EC

P304

Q30432684-CD4E518E-F22E-424F-B01C-3FE63B4217C6

P31

Q30432684-D8737706-BE55-403F-93D2-392689B9F1DF

P356

Q30432684-D26BF429-1C60-46FE-A128-5E43A1D6DC88

P407

Q30432684-7DFC73A9-D1B8-4EFF-A06E-9DA9256E7589

P433

Q30432684-AB472D1F-33FD-4D27-8350-8AA8BBBF41AE

P478

Q30432684-BEC36B79-E85E-4C05-BDD3-11CB4B604AC3

P50

Q30432684-72B0CCC4-E935-45D0-BAFB-D99E8A6C3620

Q30432684-CF0714BA-3FAD-4357-A9A7-148114A2FC96

Q30432684-DFCE6B02-2B48-44CC-986E-27A1C3E15BF0

P577

Q30432684-E906665F-47EF-49AE-8E61-2E21E1BC175A

P5875

Q30432684-515E8056-49F8-4CBB-80C6-56EBD656BE55

P698

Q30432684-11ED38FF-1B43-4F12-990D-3B98D4F38C2F

P921

Q30432684-8598F809-3C84-4E40-9BFF-196EB0E34FF6

Q30432684-B78A8480-2772-4D02-AD6E-DCFF91A3D9AB

P932

Q30432684-200F5B7B-9C7B-49A1-B1EC-8F603BCA2CDA

P356

ARCHGENPSYCHIATRY.2010.184

P1433

JAMA Psychiatry

P1476

Maintenance treatment of depre ...... antidepressant pharmacotherapy

@en

P2093

Amy Begley

http://www.w3.org/2001/XMLSchema#string

Ariel Gildengers

http://www.w3.org/2001/XMLSchema#string

Benoit H Mulsant

http://www.w3.org/2001/XMLSchema#string

Bruce G Pollock

http://www.w3.org/2001/XMLSchema#string

Charles F Reynolds

http://www.w3.org/2001/XMLSchema#string

Daniel I Kaufer

http://www.w3.org/2001/XMLSchema#string

Ellen M Whyte

http://www.w3.org/2001/XMLSchema#string

Eric J Lenze

http://www.w3.org/2001/XMLSchema#string

Jacqueline Stack

http://www.w3.org/2001/XMLSchema#string

Joan C Rogers

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

“Mini-mental state”

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Disability in late-life major depression: patterns of self-reported task abilities, task habits, and observed task performance

Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.

P304

51-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHGENPSYCHIATRY.2010.184

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Stewart Anderson

M. Ilyas Kamboh

Steven T Dekosky

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49722797

http://www.w3.org/2001/XMLSchema#string

P698

21199965

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

3076045

http://www.w3.org/2001/XMLSchema#string